Pathological effects of lacrimal keratoconjunctivitis on the ocular surface

Dry Eye and Ocular Surface Disorders

Volumn , Issue , 2004, Pages 191-203

  Yeh, Steven ^a   Pflugfelder, Stephen C ^a   Stern, Michael E ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67650341795     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (55)

1. Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren’s syndrome keratoconjunctivitis sicca. Curr Eye Res 1999; 19:201-211.
2. Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro- and antiinflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci 2001; 42:2283-2292.
3. Norn MS. Desiccation of the precorneal film. I. Corneal wetting-time. Acta Ophthalmol (Copenh) 1969; 47(4):865-880.
4. Norn MS. Desiccation of the precorneal film. II. Permanent discontinuity and dellen. Acta Ophthalmol (Copenh) 1969; 47:881-889.
5. Pflugfelder SC, Tseng SC, Sanabria O, Kell H, Garcia CG, Felix C, Feuer W, Reis BL. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea 1998; 17:38-56.
6. Liu Z, Pflugfelder SC. Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency. Ophthalmology 1999; 106:939-943.
7. de Paiva CS, Lindsey JL, Pflugfelder SC.Assessing the severity of keratitis sicca with videokeratoscopic indices. Ophthalmology 2003; 110:1102-1109.
8. Rolando M, Iester M, Macri A, Calabria G. Low spatial-contrast sensitivity in dry eyes. Cornea 1998; 17:376-379.
9. Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 2000; 107:631-639.
10. Gobbels M, Spitznas M. Effects of artificial tears on corneal epithelial permeability in dry eyes. Graefe’s Arch Clin Exp Ophthalmol 1991; 229:345-349.
11. Gobbels M, Spitznas M. Corneal epithelial permeability of dry eyes before and after treatment with artificial tears. Ophthalmology 1992; 99:873-878.
12. Huang AJ, Tseng SC, Kenyon KR. Paracellular permeability of corneal and conjunctival epithelia. Invest Ophthalmol Vis Sci 1989; 30:684-689.
13. Huang AJ, Tseng SC, Kenyon KR. Alteration of epithelial paracellular permeability during corneal epithelial wound healing. Invest Ophthalmol Vis Sci 1990; 31:429-435.
14. Dursun D, Monroy D, Knighton R, Tervo T, Vesaluoma M, Carraway K, Feuer W, Pflugfelder SC. The effects of experimental tear film removal on corneal surface regularity and barrier function. Ophthalmology 2000; 107:1754-1760.
15. Xu KP, Li XF, Yu FS. Corneal organ culture model for assessing epithelial responses to surfactants. Toxicol Sci 2000; 58:306-314.
16. Yi X, Wang Y, Yu FS. Corneal epithelial tight junctions and their response to lipopolysaccharide challenge. Invest Ophthalmol Vis Sci 2000; 41:4093-4100.
17. Pflugfelder SC, Farley W, Li D-Q, Song X, Fini E. Matrix metalloproteinase-9 (MMP-9) knockout alters the ocular surface response to experimental dryness. Invest Ophthalmol Vis Sci 2002; 43:E-Abstract 3124.
18. Afonso A, Sobrin L, Monroy DC, Selzer M, Lokeshwar B, Pflugfelder SC. Tear fluid gelatinase B activity correlates with IL-1αconcentration and fluorescein tear clearance. Invest Ophthalmol Vis Sci 1999; 40:2506-2512.
19. Sobrin L IOVS Sobrin L, Selzer MG, Lokeshwar BL, Pflugfelder SC. Stromelysin (MMP-3) activates pro-MMP-9 secreted by corneal epithelial cells. Invest Ophthalmol Vis Sci 2000; 41:1703-1709.
20. 2-terminal kinase pathway. Invest Ophthalmol Vis Sci 2002; 43:E-Abstract 1981.
21. Luo L, Li D-Q, Doshi A, Farley W, Pflugfelder SC. Experimental dry eye induced expression of inflammatory cytokines (IL-1αand TNF-α), MMP-9 and activated MAPK by the corneal epithelium Invest Ophthalmol Vis Sci 2003; 44:E-Abstract 1026.
22. Rao V, Friend J, Thoft RA, et al. Conjunctival goblet cells and mitotic rate in children with retinol deficiency and measles. Arch Ophthalmol 1987; 105:378-380.
23. Thoft RA, Friend J, Kinoshita S, et al. Ocular cicatricial pemphigoid associated with hyperproliferation of the conjunctival epithelium. Am J Opthalmol 1984; 98:37-42.
24. Weissman SS, Char DH, Herbort CP. Alteration of human conjunctival epithelial proliferation. Arch Ophthalmol 1992; 110:357-359.
25. Jones DT, Ji A, Monroy D, Pflugfelder SC. Evaluation of ocular surface cytokine, mucin, and cytokeratin expression in Sjögren’s syndrome. Adv Exp Med Biol 1998; 438:533-536.
26. Kunert KS, Tisdale AS, Gipson IK. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Arch Ophthalmol 2002; 120:330-337.
27. Nelson JD. Diagnosis of keratoconjunctivitis sicca. Int Ophthalmol Clin 1994; 34:37-56.
28. Nelson JD, Wright JC. Conjunctival goblet cell densities in ocular surface disease. Arch Ophthalmol 1984; 102:1049-1051.
29. Tseng SCG. Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology 1985; 92:728-733.
30. Pflugfelder SC, Huang AJ, Feuer W, Chuchovski PT, Pereira IC, Tseng SC. Conjunctival cytologic features of primary Sjogren’s syndrome. Ophthalmology 1990; 97:985-991.
31. Argueso P, Balaram M, Spurr-Michaud S, Keutmann HT, Dana MR, Gipson IK. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjogren syndrome. Invest Ophthalmol Vis Sci 2002; 43:1004-1011.
32. Zhao H, Jumblatt JE, Wood TO, Jumblatt MM. Quantification of MUC5AC protein in human tears. Cornea 2001; 20:873-877.
33. Danjo Y, Watanabe H, Tisdale AS, George M, Tsumura T, Abelson MB, Gipson IK. Alteration of mucin in human conjunctival epithelia in dry eye. Invest Ophthalmol Vis Sci 1998; 39:2602-2609.
34. Pflugfelder SC, Tseng SCG, Yoshino K, Monroy D, Felix C, Reis B. Correlation of goblet cell density and mucosal epithelial mucin expression with rose bengal staining in patients with ocular irritation. Ophthalmology 1997; 104:223-235.
35. Nakamura T, Nishida K, Dota A, Kinoshita S. Changes in conjunctival clusterin expression in severe ocular surface disease. Invest Ophthalmol Vis Sci 2002; 43:1702-1707.
36. Nakamura T, Nishida K, Dota A, Matsuki M, Yamanishi K, Kinoshita S. Elevated expression of transglutaminase 1 and keratinization-related proteins in conjunctiva in severe ocular surface disease. Invest Ophthalmol Vis Sci 2001; 42:549-556.
37. Gao J, Schwalb TA, Addeo JV, Ghosn CR, Stern ME. The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical cyclosporin A therapy. Cornea 1998; 17:654-663.
38. Yeh S, Song XJ, Farley W, Li DQ, Stern ME, Pflugfelder SC. Apoptosis of ocular surface cells in experimentally induced dry eye. Invest Ophthalmol Vis Sci 2003; 44:124-129.
39. Strong B, Farley W, Stern ME, Pflugfelder SC. Topical cyclosporine inhibits conjunctival apoptosis in experimental murine keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci 2002; 43:E-Abstract 2514.
40. Pflugfelder SC, Huang AJW, Schuclovski PT, Pereira IC, Tseng SCG. Conjunctival cytological features of primary Sjogren’s Syndrome. Ophthalmology 1990; 97:985-991.
41. Stern ME, Gao J, Schwalb TA, et al. Conjunctival T-cell subpopulations in Sjogren’s and non-Sjogren’s patients with dry eye. Invest Ophthalmol Vis Sci 2002; 43:2609-2614.
42. Kunert KS, Tisdale AS, Stern ME, Smith JA, Gipson IK. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol 2000; 118:1489-1496.
43. Jones DT, Yen M, Monroy D, Ji X, Atherton SS, Pflugfelder SC. Evaluation of cytokine expression in the conjunctival epithelia of Sjogren’s syndrome patients. Invest Ophthalmol Vis Sci 1994; 35:3493-3504.
44. Tishler M, Yaron I, Geyer O, Shirazi I, Naftaliev E, Yaron M. Elevated tear interleukin-6 levels in patients with Sjogren syndrome. Ophthalmology 1998; 105:2327-2329.
45. Brignole F., Pisella P.J., Goldschild M., De Saint Jean M., Goguel A., Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci 2000; 41:1356-1363.
46. Brignole F, Pisella PJ, De Saint Jean M, et al. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporine A. Invest Ophthalmol Vis Sci 2001; 42:90-95.
47. Li DQ, Tseng SC. Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol 1995; 163:61-79.
48. Li DQ, Lokeshwar BL, Solomon A, Monroy D, Ji Z, Pflugfelder SC. Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res 2001; 73:449-459.
49. Pflugfelder SC, Li D-Q, Shang TY, Lokeshwar BL. Regulation of gelatinase (MMP-2, -9), collagenases (MMP-1, -8, -13) and stromelysins (MMP-3, -10, -11) in human corneal epithelial cells by TGF-β1. Invest Ophthalmol Vis Sci 2001; 42(ARVO Abstracts):5574.
50. Li D-Q, Tie Yan Shang TY, Kim H-S, Solomon S, Lokeshwar BL, Pflugfelder SC. Regulated expression of collagenases (MMP-1, -8, -13) and stromelysins (MMP-3, -10, -11) by human corneal epithelial cells. Invest Ophthalmol Vis Sci 2003; 44:2928-2936.
51. Schonbeck U, Mach F, Libby P. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol 1998; 161:3340-3346.
52. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Ann Rev Cell Dev Biol 2001; 17:463-516.
53. Mohan R, Chintala SK, Jung JC, Villar WV, McCabe F, Russo LA, et al. Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J Biol Chem 2002; 277:2065-2072.
54. Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 2001; 21:7724-7732.
55. Liu Z, Shipley JM, Vu TH, Zhou X, Diaz LA, Werb Z, et al. Gelatinase B deficienct mice are resistant to experimental bullous pemphigoid. J Exp Med Biol 1998; 188:475-482.